Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Curaleaf Holdings Inc (OP: CURLF )

5.290 -0.300 (-5.37%)
Streaming Delayed Price Updated: 3:59 PM EDT, May 20, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 641,150
Open 5.550
Bid (Size) N/A (0)
Ask (Size) N/A (0)
Prev. Close 5.590
Today's Range 5.050 - 5.680
52wk Range 2.510 - 6.400
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Easy-To-Trade Cannabis Stocks: Insights Into How Trading Activity Affects These Investments
The trading volume of a stock reflects the number of shares bought and sold within a given time. This is called liquidity. The term is used because it likens the ease of converting assets to cash to... 
Via Benzinga
Topics Cannabis
Exposures Cannabis
Cannabis Stocks Under $2: Why Are These Small-Cap Shares Up While Broader Sector Is In The Red?
Four lesser-valued cannabis stocks showed positive performance on Monday, defying the broader sector's downtrend. These stocks—Medical Marijuana Inc., TILT Holdings, Trees Corp., and Village Farms... 
Via Benzinga
Topics Cannabis
Exposures Cannabis

Performance

YTD
+31.92%
+31.92%
1 Month
+9.75%
+9.75%
3 Month
+5.80%
+5.80%
6 Month
+51.58%
+51.58%
1 Year
+75.75%
+75.75%

More News

Read More
Bearish Monday For Marijuana Stocks - Flower One Hldgs, SOL Glb Inv Among Top Gainers
Via Benzinga
Topics Cannabis
Exposures Cannabis
Is Aurora Cannabis Stock a Buy?
Via The Motley Fool
Topics Cannabis
Exposures Cannabis
American Cannabis MSOs Portfolio Reversed Direction Last Week
Via Talk Markets
Topics Cannabis
Exposures Cannabis
Cannabis Meets Prescription Drugs, Steroids And Ketamine In Schedule III: What It Means, Key Stocks To Watch
Via Benzinga
Topics Cannabis
Exposures Cannabis
Curaleaf's Boris Jordan Says Rescheduling Cannabis Will Save Industry $200M In Revenue, Bring Illicit Market In From The Cold
Via Benzinga
Topics Cannabis
Exposures Cannabis
3 Undiscovered OTC Stocks to Buy for Multibagger Returns
Via InvestorPlace
Finally, Tax Refunds! These Cannabis Companies Will Get The Most Money Back If Rescheduling Happens
Via Benzinga
Topics Cannabis
Exposures Cannabis
Biden Announces 'Monumental' Marijuana Rescheduling, DOJ To Take Next Steps
Via Benzinga
Topics Cannabis
Exposures Cannabis
Pitch Your Cannabis Business And Win Thousands In Prizes At This Benzinga & Curaleaf Competition
Via Benzinga
Topics Cannabis
Exposures Cannabis
Breathalyzer Innovations Meet Rising Demand as Cannabis Market Booms
From Financial Buzz Media
Via GlobeNewswire
Wall Street Favorites: 3 Cannabis Stocks with Strong Buy Ratings for May 2024
Via InvestorPlace
Topics Cannabis
Exposures Cannabis
Largest Cannabis Co. Curaleaf's $1.5B Projected Revenue For 2025: Analyst Raises Rating To Outperform
Via Benzinga
Topics Cannabis
Exposures Cannabis
Florida Cannabis Legalization Amendment Ads Hit Airwaves: The First 4 Pitches For Legal Weed In The Sunshine State
Via Benzinga
Topics Cannabis
Exposures Cannabis
3 Companies to Watch as Nasdaq Warms Up to Cannabis Listings
Via InvestorPlace
Topics Cannabis
Exposures Cannabis
Cannabis Shops Could Launch This Year In Germany For 'Scientific Purposes,' Here's Why UK's Medical Marijuana Sales Are Soaring
Via Benzinga
Topics Cannabis
Exposures Cannabis
The 7 Most Undervalued Cannabis Stocks to Buy in May 2024
Via InvestorPlace
Topics Cannabis
Exposures Cannabis
American Cannabis MSOs Portfolio Down 5% On The Week
Via Talk Markets
Topics Cannabis
Exposures Cannabis
Cannabis Reports Highlight $339M And $297.6M Revenue Insights In Curaleaf And Trulieve's Q1 2024 Financials
Via Benzinga
Topics Cannabis
Exposures Cannabis
3 Undiscovered Stocks to Buy for 3-Bagger Returns by 2025
Via InvestorPlace
CURLF Stock Earnings: Curaleaf Holdings Misses EPS, Misses Revenue for Q1 2024
Via InvestorPlace
Curaleaf Reports Q1 2024 Revenue Of $339M, 48% Gross Margin Amid Strategic Global Expansion
Via Benzinga
Topics Cannabis
Exposures Cannabis
Curaleaf Reports 16% Reduction In Net Loss In Q1 Financial Report
Via Talk Markets
7 Cannabis Stocks to Buy for a Smoking-Hot 2024
Via InvestorPlace
Topics Cannabis
Exposures Cannabis
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.